Orange Lands $46M Manufacturing Project For Garonit Pharma Near Stewart Airport
NEW WINDSOR, NY— Garonit Pharmaceutical, Inc., a global manufacturer of antiseptic products and health care solutions headquartered in Fairfield, NJ, will build a new state-of-the-art, 200,000sf pharmaceutical manufacturing facility here in Orange County.
The $46.1-million project, to be built on a vacant parcel adjacent to New York Stewart International Airport, will become the world’s largest chlorhexidine gluconate manufacturing operation, producing antiseptic products essential for surgical disinfection and infection prevention in hospitals worldwide, said New York State officials who announced the deal on Aug. 4. The state is supporting the project with $3.8 million, including up to $3.5 million through the Excelsior Jobs Program and a $300,000 Mid-Hudson Regional Economic Development Council capital grant.
The new facility will manufacture antiseptic products, including both ANDA and NDA formulations that are subject to full U.S. Food and Drug Administration approval.
The products to be manufactured at this site are commonly used in hospital settings, particularly in surgical environments. The facility will feature advanced production lines for liquid finished dosage forms and a state-of-the-art laboratory equipped with advanced analytical equipment for quality testing and research.
Construction is scheduled to begin in the first quarter of 2026 with production operations anticipated to start in January 2027. The project will create an estimated 100 to 150 construction jobs during the build phase. The 100 full-time pharmaceutical positions will include production, quality assurance, warehouse, R&D, administration and logistics, management and sales roles. The facility will export products to existing customers across North America, Europe, Japan, Australia, and other global markets.
The Orange County Partnership of Goshen, NY worked directly with Garonit executives over the past year on site selection efforts. Garonit Pharmaceutical has begun collaborating with SUNY Orange Community College to develop specialized training programs that will prepare local residents for these high-skill positions
Garonit Pharmaceutical Inc. Owner Nitin Garg said, “This milestone is strengthened by our collaboration with SUNY Orange as we work together to develop programs that bridge operational excellence with advanced research and development.”
Published: August 15, 2025.